You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 40 No. 9, September 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Lysosomal and Nonlysosomal Hydrolases of Skeletal Muscle in Neuromuscular Diseases

Timo E. S. Takala, MD, PhD; Vilho V. Myllylä, MD, PhD; Antero Salminen, MSc; Uolevi Tolonen, MD, PhD; Ilmo E. Hassinen, MD, PhD; Veikko Vihko, PhD

Arch Neurol. 1983;40(9):541-544.


Abstract

• The activities of four lysosomal and two nonlysosomal hydrolases were studied in skeletal muscle biopsy samples from patients with neuromuscular diseases and from controls. β-Glucosaminidase activity was increased in polymyositis. β-Glucuronidase and alkaline protease activities were elevated in muscular dystrophy in adults, whereas cathepsin D activity was increased in amyotrophic lateral sclerosis. There were significant correlations between the activities of lysosomal and nonlysosomal hydrolases. The activity of β-glucuronidase, β-glucosaminidase, alkaline protease, and dipeptidyl aminopeptidase IV showed a positive correlation with the severity of muscular atrophy. The activities of these hydrolases and the activity of dipeptidyl aminopeptidase I correlated positively with the activities of muscular galactosylhydroxylysyl glucosyltransferase and with the serum concentration of type III procollagen aminoterminal propeptide. The results suggest that in neuromuscular diseases the lysosomal and nonlysosomal pathways for muscle degradation are affected concomitantly with collagen biosynthesis.



Author Affiliations

From the Departments of Clinical Chemistry (Dr Takala), Neurology (Drs Myllylä and Tolonen), and Medical Biochemistry (Dr Hassinen), University of Oulu (Finland), and the Department of Cell Biology (Mr Salminen and Dr Vihko), University of Jyväskylä (Finland).


Footnotes

Accepted for publication Dec 29, 1982.

Reprint requests to the Department of Neurology, University of Oulu, SF-90220 Oulu 22, Finland (Dr Myllylä).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.